Literature DB >> 24282108

Identification of inflamed atherosclerotic lesions in vivo using PET-CT.

Mateja Kaja Jezovnik1, Nina Zidar, Luka Lezaic, Borut Gersak, Pavel Poredos.   

Abstract

Inflammation plays a major pathogenetic role in the development of atherosclerotic plaques and related thromboembolic events. The identification of vulnerable plaques is of the utmost importance, as this may allow the implementation of more effective preventive and therapeutic interventions. Fluorodeoxyglucose positron emission tomography (FDG-PET) has been shown to be useful for tracing inflammation within plaques. However, its relationship to immunohistochemical findings in different territories of the peripheral circulation was not completely elucidated. We aimed to determine whether plaque inflammation could be measured by PET in combination with computer tomography (CT) using FDG and what is the relationship between FDG uptake and immunohistochemical findings in the removed atherosclerotic lesions of the femoral and carotid arteries. The study included 31 patients, 21 patients with high-grade stenosis of the internal carotid artery (ICA) and 10 patients with occlusion of the common femoral artery (CFA), all of whom underwent endarterectomy. Before endarterectomy in all patients, FDG-PET/CT imaging was performed. FDG uptake was measured as the maximum blood--normalized standardized uptake value, known as the target to background ratio (TBR max). TBR max amounted to 1.72 ± 0.8, and in patients with ICA, stenosis was not significantly different from patients with CFA occlusion. Immunohistochemical and morphometric analyses of the plaques obtained at endarterectomy showed that the density of T lymphocytes and macrophages (number of cells per square millimeter) was significantly higher in subjects with stenosis of the ICA than in subjects with occlusion of the femoral arteries: lymphocytes, 1.26 ± 0.21 vs. 0.77 ± 0.29; p = 0.02 and macrophages, 1.01 ± 0.18 vs. 0.69 ± 0.23; p = 0.003. In the whole group of patients, the density of inflammatory cells significantly correlated with FDG uptake represented by PET-TBR max: T lymphocytes, r = 0.60; p < 0.01 and macrophages, r = 0.65; p < 0.01. The results of our study show that FDG uptake is related to the accumulation of inflammatory cells in atherosclerotic lesions. This finding suggests that FDG uptake reflects the severity of atherosclerotic vessel wall inflammation, and in stenotic lesions, it could be an indicator of their vulnerability. However, data from large outcome studies is needed to estimate the usefulness of this technique in identifying the most dangerous atherosclerotic lesions and vulnerable patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24282108     DOI: 10.1007/s10753-013-9755-3

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  34 in total

1.  Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography/computed tomography.

Authors:  Oliver Gaemperli; Joseph Shalhoub; David R J Owen; Frederic Lamare; Saga Johansson; Naghmeh Fouladi; Alun H Davies; Ornella E Rimoldi; Paolo G Camici
Journal:  Eur Heart J       Date:  2011-09-19       Impact factor: 29.983

2.  Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.

Authors:  P M Ridker; N Rifai; M Clearfield; J R Downs; S E Weis; J S Miles; A M Gotto
Journal:  N Engl J Med       Date:  2001-06-28       Impact factor: 91.245

3.  Identifying high-risk asymptomatic carotid stenosis.

Authors:  Chrysi Bogiatzi; Myra S Cocker; Robert Beanlands; J David Spence
Journal:  Expert Opin Med Diagn       Date:  2012-02-17

4.  Investigating vulnerable atheroma using combined (18)F-FDG PET/CT angiography of carotid plaque with immunohistochemical validation.

Authors:  Leon J Menezes; Carl W Kotze; Obi Agu; Toby Richards; Jocelyn Brookes; Vicky J Goh; Manuel Rodriguez-Justo; Raymondo Endozo; Richard Harvey; Syed W Yusuf; Peter J Ell; Ashley M Groves
Journal:  J Nucl Med       Date:  2011-10-11       Impact factor: 10.057

5.  (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials.

Authors:  James H F Rudd; Kelly S Myers; Sameer Bansilal; Josef Machac; Ash Rafique; Michael Farkouh; Valentin Fuster; Zahi A Fayad
Journal:  J Am Coll Cardiol       Date:  2007-08-13       Impact factor: 24.094

6.  Augmentation effects of lymphocyte activation by antigen-presenting macrophages on FDG uptake.

Authors:  Masanori Shozushima; Reiko Tsutsumi; Kazunori Terasaki; Shigehiro Sato; Ryuji Nakamura; Kimio Sakamaki
Journal:  Ann Nucl Med       Date:  2003-10       Impact factor: 2.668

7.  18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease.

Authors:  Axel Rominger; Tobias Saam; Sarah Wolpers; Clemens C Cyran; Michael Schmidt; Stefan Foerster; Konstantin Nikolaou; Maximilian F Reiser; Peter Bartenstein; Marcus Hacker
Journal:  J Nucl Med       Date:  2009-09-16       Impact factor: 10.057

8.  Reversal of vascular 18F-FDG uptake with plasma high-density lipoprotein elevation by atherogenic risk reduction.

Authors:  Su Jin Lee; Young Keun On; Eun Jeong Lee; Joon Young Choi; Byung-Tae Kim; Kyung-Han Lee
Journal:  J Nucl Med       Date:  2008-07-16       Impact factor: 10.057

Review 9.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

Authors:  Morteza Naghavi; Peter Libby; Erling Falk; S Ward Casscells; Silvio Litovsky; John Rumberger; Juan Jose Badimon; Christodoulos Stefanadis; Pedro Moreno; Gerard Pasterkamp; Zahi Fayad; Peter H Stone; Sergio Waxman; Paolo Raggi; Mohammad Madjid; Alireza Zarrabi; Allen Burke; Chun Yuan; Peter J Fitzgerald; David S Siscovick; Chris L de Korte; Masanori Aikawa; K E Juhani Airaksinen; Gerd Assmann; Christoph R Becker; James H Chesebro; Andrew Farb; Zorina S Galis; Chris Jackson; Ik-Kyung Jang; Wolfgang Koenig; Robert A Lodder; Keith March; Jasenka Demirovic; Mohamad Navab; Silvia G Priori; Mark D Rekhter; Raymond Bahr; Scott M Grundy; Roxana Mehran; Antonio Colombo; Eric Boerwinkle; Christie Ballantyne; William Insull; Robert S Schwartz; Robert Vogel; Patrick W Serruys; Goran K Hansson; David P Faxon; Sanjay Kaul; Helmut Drexler; Philip Greenland; James E Muller; Renu Virmani; Paul M Ridker; Douglas P Zipes; Prediman K Shah; James T Willerson
Journal:  Circulation       Date:  2003-10-07       Impact factor: 29.690

10.  Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography.

Authors:  J H F Rudd; E A Warburton; T D Fryer; H A Jones; J C Clark; N Antoun; P Johnström; A P Davenport; P J Kirkpatrick; B N Arch; J D Pickard; P L Weissberg
Journal:  Circulation       Date:  2002-06-11       Impact factor: 29.690

View more
  6 in total

Review 1.  Macrophages in vascular inflammation--From atherosclerosis to vasculitis.

Authors:  Tsuyoshi Shirai; Marc Hilhorst; David G Harrison; Jörg J Goronzy; Cornelia M Weyand
Journal:  Autoimmunity       Date:  2015-03-26       Impact factor: 2.815

2.  Dual-Modality Activity-Based Probes as Molecular Imaging Agents for Vascular Inflammation.

Authors:  Nimali P Withana; Toshinobu Saito; Xiaowei Ma; Megan Garland; Changhao Liu; Hisanori Kosuge; Myriam Amsallem; Martijn Verdoes; Leslie O Ofori; Michael Fischbein; Mamoru Arakawa; Zhen Cheng; Michael V McConnell; Matthew Bogyo
Journal:  J Nucl Med       Date:  2016-05-19       Impact factor: 10.057

Review 3.  Searching for novel PET radiotracers: imaging cardiac perfusion, metabolism and inflammation.

Authors:  Caitlund Q Davidson; Christopher P Phenix; T C Tai; Neelam Khaper; Simon J Lees
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-06-05

4.  FDG-PET/CT pitfalls in oncological head and neck imaging.

Authors:  Bela S Purohit; Angeliki Ailianou; Nicolas Dulguerov; Christoph D Becker; Osman Ratib; Minerva Becker
Journal:  Insights Imaging       Date:  2014-08-26

5.  Patients with an Inflamed Atherosclerotic Plaque have Increased Levels of Circulating Inflammatory Markers.

Authors:  Pavel Poredos; Ana Spirkoska; Luka Lezaic; Mojca Božič Mijovski; Mateja Kaja Jezovnik
Journal:  J Atheroscler Thromb       Date:  2016-05-26       Impact factor: 4.928

Review 6.  Inflammation of carotid plaques and risk of cerebrovascular events.

Authors:  Pavel Poredos; Igor D Gregoric; Mateja K Jezovnik
Journal:  Ann Transl Med       Date:  2020-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.